Latest Insights on SWKH
Biopharma Startups Need $$$ for R&D: That’s Where This Power Stock Comes In May 23, 2022 Money & Markets Daily
Biopharma companies spend at least 25% of their revenue on research and development (R&D) … but this is a problem for new companies with no revenue to draw from. This Power Stock helps biopharma companies find capital and rates a perfect 100 on our proprietary system.